JPY 2454.0
(1.95%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | 28.98 Billion JPY | -12.74% |
2022 | 33.21 Billion JPY | -18.04% |
2021 | 40.52 Billion JPY | 0.85% |
2020 | 40.18 Billion JPY | 53.55% |
2019 | 26.17 Billion JPY | -5.66% |
2018 | 27.73 Billion JPY | 18.37% |
2017 | 23.43 Billion JPY | -12.21% |
2016 | 26.69 Billion JPY | -14.84% |
2015 | 31.34 Billion JPY | 647.02% |
2014 | 4.19 Billion JPY | -1.47% |
2013 | 4.25 Billion JPY | -81.91% |
2012 | 23.54 Billion JPY | -17.22% |
2011 | 28.44 Billion JPY | -7.56% |
2010 | 30.77 Billion JPY | 7.99% |
2009 | 28.5 Billion JPY | 56.45% |
2008 | 18.21 Billion JPY | 35.14% |
2007 | 13.47 Billion JPY | -7.84% |
2006 | 14.62 Billion JPY | 25.06% |
2005 | 11.69 Billion JPY | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q1 | 24.51 Billion JPY | -15.43% |
2023 Q4 | 28.98 Billion JPY | -6.9% |
2023 Q3 | 31.12 Billion JPY | -2.99% |
2023 Q2 | 32.08 Billion JPY | -4.95% |
2023 FY | 28.98 Billion JPY | -12.74% |
2023 Q1 | 33.76 Billion JPY | 1.65% |
2022 Q3 | 35.17 Billion JPY | -9.23% |
2022 FY | 33.21 Billion JPY | -18.04% |
2022 Q4 | 33.21 Billion JPY | -5.59% |
2022 Q1 | 39.5 Billion JPY | -2.52% |
2022 Q2 | 38.75 Billion JPY | -1.89% |
2021 Q4 | 40.52 Billion JPY | -0.92% |
2021 Q1 | 41.08 Billion JPY | 2.24% |
2021 FY | 40.52 Billion JPY | 0.85% |
2021 Q3 | 40.89 Billion JPY | -0.53% |
2021 Q2 | 41.11 Billion JPY | 0.08% |
2020 Q2 | 30.6 Billion JPY | 1.18% |
2020 Q3 | 28.18 Billion JPY | -7.92% |
2020 Q4 | 40.18 Billion JPY | 42.6% |
2020 FY | 40.18 Billion JPY | 53.55% |
2020 Q1 | 30.24 Billion JPY | 15.57% |
2019 FY | 26.17 Billion JPY | -5.66% |
2019 Q4 | 26.17 Billion JPY | -11.19% |
2019 Q3 | 29.46 Billion JPY | 0.48% |
2019 Q2 | 29.32 Billion JPY | -0.43% |
2019 Q1 | 29.45 Billion JPY | 6.18% |
2018 Q2 | 25.75 Billion JPY | 5.67% |
2018 FY | 27.73 Billion JPY | 18.37% |
2018 Q1 | 24.36 Billion JPY | 3.98% |
2018 Q3 | 28.25 Billion JPY | 9.7% |
2018 Q4 | 27.73 Billion JPY | -1.81% |
2017 Q3 | 26.24 Billion JPY | -6.39% |
2017 Q1 | 28.61 Billion JPY | 7.21% |
2017 FY | 23.43 Billion JPY | -12.21% |
2017 Q4 | 23.43 Billion JPY | -10.7% |
2017 Q2 | 28.03 Billion JPY | -2.04% |
2016 FY | 26.69 Billion JPY | -14.84% |
2016 Q2 | 31.03 Billion JPY | 3.58% |
2016 Q1 | 29.96 Billion JPY | -4.43% |
2016 Q3 | 30.24 Billion JPY | -2.54% |
2016 Q4 | 26.69 Billion JPY | -11.74% |
2015 Q1 | 3.51 Billion JPY | -16.36% |
2015 FY | 31.34 Billion JPY | 647.02% |
2015 Q4 | 31.34 Billion JPY | -7.3% |
2015 Q3 | 33.81 Billion JPY | 3.12% |
2015 Q2 | 32.79 Billion JPY | 834.24% |
2014 Q4 | 4.19 Billion JPY | -19.08% |
2014 Q2 | 5.53 Billion JPY | 21.8% |
2014 Q3 | 5.18 Billion JPY | -6.22% |
2014 FY | 4.19 Billion JPY | -1.47% |
2014 Q1 | 4.54 Billion JPY | 6.61% |
2013 FY | 4.25 Billion JPY | -81.91% |
2013 Q1 | 22.81 Billion JPY | -3.12% |
2013 Q2 | 22.5 Billion JPY | -1.37% |
2013 Q3 | 23.18 Billion JPY | 3.04% |
2013 Q4 | 4.25 Billion JPY | -81.63% |
2012 Q1 | 29.06 Billion JPY | 2.18% |
2012 FY | 23.54 Billion JPY | -17.22% |
2012 Q4 | 23.54 Billion JPY | -18.12% |
2012 Q3 | 28.76 Billion JPY | 0.62% |
2012 Q2 | 28.58 Billion JPY | -1.66% |
2011 Q1 | 30.23 Billion JPY | -1.75% |
2011 Q2 | 29.45 Billion JPY | -2.57% |
2011 Q4 | 28.44 Billion JPY | -5.35% |
2011 FY | 28.44 Billion JPY | -7.56% |
2011 Q3 | 30.05 Billion JPY | 2.03% |
2010 Q3 | 31.91 Billion JPY | -0.32% |
2010 FY | 30.77 Billion JPY | 7.99% |
2010 Q2 | 32.02 Billion JPY | 12.54% |
2010 Q1 | 28.45 Billion JPY | -0.17% |
2010 Q4 | 30.77 Billion JPY | -3.58% |
2009 Q3 | 29.57 Billion JPY | 0.88% |
2009 Q4 | 28.5 Billion JPY | -3.63% |
2009 Q2 | 29.31 Billion JPY | 0.0% |
2009 FY | 28.5 Billion JPY | 56.45% |
2008 Q3 | 18.87 Billion JPY | 0.0% |
2008 Q4 | 18.21 Billion JPY | -3.51% |
2008 FY | 18.21 Billion JPY | 35.14% |
2007 FY | 13.47 Billion JPY | -7.84% |
2006 FY | 14.62 Billion JPY | 25.06% |
2005 FY | 11.69 Billion JPY | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Pharma Foods International Co., Ltd. | 1.22 Billion JPY | -2265.858% |
Takeda Pharmaceutical Company Limited | 4385.95 Billion JPY | 99.339% |
Sumitomo Pharma Co., Ltd. | 389.83 Billion JPY | 92.566% |
Shionogi & Co., Ltd. | -346.47 Billion JPY | 108.365% |
Wakamoto Pharmaceutical Co.,Ltd. | -3.56 Billion JPY | 913.154% |
Nippon Shinyaku Co., Ltd. | -42.15 Billion JPY | 168.749% |
Kaken Pharmaceutical Co., Ltd. | -61.47 Billion JPY | 147.145% |
Eisai Co., Ltd. | -97.93 Billion JPY | 129.594% |
Morishita Jintan Co., Ltd. | -667 Million JPY | 4445.092% |
Hisamitsu Pharmaceutical Co., Inc. | -51.82 Billion JPY | 155.927% |
Mochida Pharmaceutical Co., Ltd. | -32.92 Billion JPY | 188.034% |
Fuso Pharmaceutical Industries,Ltd. | 7.6 Billion JPY | -281.239% |
Nippon Chemiphar Co., Ltd. | 7.78 Billion JPY | -272.468% |
Tsumura & Co. | 1.61 Billion JPY | -1694.536% |
Kissei Pharmaceutical Co., Ltd. | -44.16 Billion JPY | 165.629% |
Torii Pharmaceutical Co., Ltd. | -34.43 Billion JPY | 184.159% |
Towa Pharmaceutical Co., Ltd. | 172.7 Billion JPY | 83.219% |
Fuji Pharma Co., Ltd. | 26.62 Billion JPY | -8.856% |
KYORIN Holdings, Inc. | 7.06 Billion JPY | -310.507% |
Taiko Pharmaceutical Co.,Ltd. | 704 Million JPY | -4016.728% |
Daito Pharmaceutical Co.,Ltd. | 5.99 Billion JPY | -383.674% |
SymBio Pharmaceuticals Limited | -6.51 Billion JPY | 544.71% |
MedRx Co., Ltd | -1.72 Billion JPY | 1784.986% |
Mizuho Medy Co.,Ltd. | -8.71 Billion JPY | 432.494% |
Solasia Pharma K.K. | -668 Million JPY | 4438.587% |
Modalis Therapeutics Corporation | -1.47 Billion JPY | 2070.293% |
ASKA Pharmaceutical Holdings Co.,Ltd. | -7.25 Billion JPY | 499.583% |
Sawai Group Holdings Co., Ltd. | 56.52 Billion JPY | 48.725% |
Cyfuse Biomedical K.K. | -2.96 Billion JPY | 1078.858% |
Toho Holdings Co., Ltd. | -98.42 Billion JPY | 129.444% |
Koa Shoji Holdings Co.,Ltd. | -11.12 Billion JPY | 360.403% |